Ligand Pharmaceuticals Inc 10-K for FY2019
Ligand Pharmaceuticals Inc (LGND)
10-K
2020-02-27
For: 2019-12-31
View Original
Added on
April 06, 2026
About this 10-K
Ligand Pharmaceuticals Inc filed this 10-K on February 27, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $120.28M
- down 52.2% from $251.45M a year earlier
- Net income
- $629.3M
- up 339.1% from net income of $143.32M a year earlier
- Diluted EPS
- $31.85
- up 434.4% from $5.96 a year earlier